semaglutide lower blood sugar for Prediabetes: A Guide to Preventing Type 2 Diabetes Semaglutide in Houston, TX -

Discontinuation and weight regain How often people stop the medication TRIUMPH-4 (n=445, 68 weeks, obesity with knee osteoarthritis): 18.2% on 12 mg, 12.2% on 9 mg, 4% on placebo 2 TRANSCEND-T2D-1 (n=537, 40 weeks, type 2 diabetes): 5.1% on 12 mg, 4.5% on 9 mg, 0% on placebo 3 Phase 2 (n=338, 48 weeks): 6 to 16% across doses, 1% on placebo 1 For comparison, Wegovys STEP-1 trial reported a discontinuation rate of around 7% due to side effects, and Mounjaros SURMOUNT-1 reported a similar rate

Anim Feed Sci Technol 281

Our guide on BMI requirements for GLP-1 medications covers the qualification criteria in detail

The fitness and wellness software giant has launched Elevate Wellness, a program designed to help gyms and clubs provide GLP-1 support and other telehealth offerings through physician-guided metabolic health services

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN 6)